230 related articles for article (PubMed ID: 15996004)
1. Alkoxycarbonyloxyethyl ester prodrugs of FR900098 with improved in vivo antimalarial activity.
Ortmann R; Wiesner J; Reichenberg A; Henschker D; Beck E; Jomaa H; Schlitzer M
Arch Pharm (Weinheim); 2005 Jul; 338(7):305-14. PubMed ID: 15996004
[TBL] [Abstract][Full Text] [Related]
2. Double ester prodrugs of FR900098 display enhanced in-vitro antimalarial activity.
Wiesner J; Ortmann R; Jomaa H; Schlitzer M
Arch Pharm (Weinheim); 2007 Dec; 340(12):667-9. PubMed ID: 17994601
[TBL] [Abstract][Full Text] [Related]
3. Diaryl ester prodrugs of FR900098 with improved in vivo antimalarial activity.
Reichenberg A; Wiesner J; Weidemeyer C; Dreiseidler E; Sanderbrand S; Altincicek B; Beck E; Schlitzer M; Jomaa H
Bioorg Med Chem Lett; 2001 Mar; 11(6):833-5. PubMed ID: 11277531
[TBL] [Abstract][Full Text] [Related]
4. Acyloxyalkyl ester prodrugs of FR900098 with improved in vivo anti-malarial activity.
Ortmann R; Wiesner J; Reichenberg A; Henschker D; Beck E; Jomaa H; Schlitzer M
Bioorg Med Chem Lett; 2003 Jul; 13(13):2163-6. PubMed ID: 12798327
[TBL] [Abstract][Full Text] [Related]
5. Studies addressing the importance of charge in the binding of fosmidomycin-like molecules to deoxyxylulosephosphate reductoisomerase.
Perruchon J; Ortmann R; Altenkämper M; Silber K; Wiesner J; Jomaa H; Klebe G; Schlitzer M
ChemMedChem; 2008 Aug; 3(8):1232-41. PubMed ID: 18470849
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of alpha,beta-unsaturated alpha-aryl-substituted fosmidomycin analogues as DXR inhibitors.
Devreux V; Wiesner J; Jomaa H; Van der Eycken J; Van Calenbergh S
Bioorg Med Chem Lett; 2007 Sep; 17(17):4920-3. PubMed ID: 17583502
[TBL] [Abstract][Full Text] [Related]
7. Reverse fosmidomycin derivatives against the antimalarial drug target IspC (Dxr).
Behrendt CT; Kunfermann A; Illarionova V; Matheeussen A; Pein MK; Gräwert T; Kaiser J; Bacher A; Eisenreich W; Illarionov B; Fischer M; Maes L; Groll M; Kurz T
J Med Chem; 2011 Oct; 54(19):6796-802. PubMed ID: 21866890
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antiplasmodial activity of highly active reverse analogues of the antimalarial drug candidate fosmidomycin.
Behrendt CT; Kunfermann A; Illarionova V; Matheeussen A; Gräwert T; Groll M; Rohdich F; Bacher A; Eisenreich W; Fischer M; Maes L; Kurz T
ChemMedChem; 2010 Oct; 5(10):1673-6. PubMed ID: 20718073
[No Abstract] [Full Text] [Related]
9. Novel deoxyxylulosephosphate-reductoisomerase inhibitors: fosmidomycin derivatives with spacious acyl residues.
Ortmann R; Wiesner J; Silber K; Klebe G; Jomaa H; Schlitzer M
Arch Pharm (Weinheim); 2007 Sep; 340(9):483-90. PubMed ID: 17806130
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs.
Jomaa H; Wiesner J; Sanderbrand S; Altincicek B; Weidemeyer C; Hintz M; Türbachova I; Eberl M; Zeidler J; Lichtenthaler HK; Soldati D; Beck E
Science; 1999 Sep; 285(5433):1573-6. PubMed ID: 10477522
[TBL] [Abstract][Full Text] [Related]
11. Towards new antimalarial drugs: synthesis of non-hydrolyzable phosphate mimics as feed for a predictive QSAR study on 1-deoxy-D-xylulose-5-phosphate reductoisomerase inhibitors.
Giessmann D; Heidler P; Haemers T; Van Calenbergh S; Reichenberg A; Jomaa H; Weidemeyer C; Sanderbrand S; Wiesner J; Link A
Chem Biodivers; 2008 Apr; 5(4):643-56. PubMed ID: 18421757
[TBL] [Abstract][Full Text] [Related]
12. Non-mevalonate isoprenoid biosynthesis: enzymes, genes and inhibitors.
Lichtenthaler HK
Biochem Soc Trans; 2000 Dec; 28(6):785-9. PubMed ID: 11171208
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of fosmidomycin analogs as inhibitors of the Synechocystis sp. PCC6803 1-deoxy-D-xylulose 5-phosphate reductoisomerase.
Woo YH; Fernandes RP; Proteau PJ
Bioorg Med Chem; 2006 Apr; 14(7):2375-85. PubMed ID: 16310360
[TBL] [Abstract][Full Text] [Related]
14. 1-Deoxy-D-xylulose 5-phosphate reductoisomerase: an overview.
Proteau PJ
Bioorg Chem; 2004 Dec; 32(6):483-93. PubMed ID: 15530989
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of phosphonated N-heteroarylcarboxamides as DOXP-reductoisomerase (DXR) inhibitors.
Bodill T; Conibear AC; Blatch GL; Lobb KA; Kaye PT
Bioorg Med Chem; 2011 Feb; 19(3):1321-7. PubMed ID: 21216609
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of cyclopropyl analogues of fosmidomycin as potent Plasmodium falciparum growth inhibitors.
Devreux V; Wiesner J; Goeman JL; Van der Eycken J; Jomaa H; Van Calenbergh S
J Med Chem; 2006 Apr; 49(8):2656-60. PubMed ID: 16610809
[TBL] [Abstract][Full Text] [Related]
17. Growth inhibition of Mycobacterium smegmatis by prodrugs of deoxyxylulose phosphate reducto-isomerase inhibitors, promising anti-mycobacterial agents.
Ponaire S; Zinglé C; Tritsch D; Grosdemange-Billiard C; Rohmer M
Eur J Med Chem; 2012 May; 51():277-85. PubMed ID: 22405649
[TBL] [Abstract][Full Text] [Related]
18. Properties and inhibition of the first two enzymes of the non-mevalonate pathway of isoprenoid biosynthesis.
Mueller C; Schwender J; Zeidler J; Lichtenthaler HK
Biochem Soc Trans; 2000 Dec; 28(6):792-3. PubMed ID: 11171210
[TBL] [Abstract][Full Text] [Related]
19. AFMoC enhances predictivity of 3D QSAR: a case study with DOXP-reductoisomerase.
Silber K; Heidler P; Kurz T; Klebe G
J Med Chem; 2005 May; 48(10):3547-63. PubMed ID: 15887963
[TBL] [Abstract][Full Text] [Related]
20. α-Substituted β-oxa isosteres of fosmidomycin: synthesis and biological evaluation.
Brücher K; Illarionov B; Held J; Tschan S; Kunfermann A; Pein MK; Bacher A; Gräwert T; Maes L; Mordmüller B; Fischer M; Kurz T
J Med Chem; 2012 Jul; 55(14):6566-75. PubMed ID: 22731758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
